


If the employee is not required to be removed by the mandatory provisions of this subsection or by the physician's determination, then until the employee's CdU level falls to or below 3 μg/g Cr, β 2-M level falls to or below 300 μg/g Cr and CdB level falls to or below 5 μg/lwb, the employer shall: periodically reassess the employee's occupational exposure to cadmium provide biological monitoring in accordance with subsection ( l)(2)(B)2. If the second set of biological monitoring results obtained during the medical examination does not show that a mandatory removal trigger level has been exceeded, then the employee is not required to be removed by the mandatory provisions of this subsection. However, if the initial biological monitoring results and the biological monitoring results obtained during the medical examination both show that: CdU exceeds 7 μg/g Cr or CdB exceeds 10 μg/lwb or β 2-M exceeds 750 μg/g Cr, and in addition CdU exceeds 3 μg/g Cr or CdB exceeds 5 μg/liter of whole blood, then the physician shall medically remove the employee from exposure to cadmium at or above the action level. After completing the medical examination, the examining physician shall determine in a written medical opinion whether to medically remove the employee.
CAL OSHA BREATHING ZONE FULL
and, within 90 days after receipt of biological monitoring results, provide a full medical examination to the employee in accordance with the requirements of subsection ( l)(4)(B). If the results of the initial biological monitoring tests show the level of CdU to be in excess of 7 μg/g Cr, or the level of CdB to be in excess of 10 μg/lwb, or the level of β 2-M to be in excess of 750 μg/g Cr, the employer shall: comply with the requirements of subsections ( l)(3)(B)1.-2. If the employee is not required to be removed by the mandatory provisions of this subsection or by the physician's determination, then until the employee's CdU level falls to or below 3 μg/g Cr, β 2-M level falls to or below 300 μg/g Cr and CdB level falls to or below 5 μg/lwb, the employer shall:ģ.

However, if the initial biological monitoring results and the biological monitoring results obtained during the medical examination both show that: CdU exceeds 15 μg/g Cr or CdB exceeds 15 μg/lwb or β 2-M exceeds 1500 μg/g Cr, and in addition CdU exceeds 3 μg/g Cr or CdB exceeds 5 μg/liter of whole blood, then the physician shall medically remove the employee from exposure to cadmium at or above the action level. Within 90 days after receipt of biological monitoring results, the employer shall provide a full medical examination to the employee in accordance with the requirements of subsection ( l)(4)(B). (C) For all employees who are subject to medical surveillance under subsection ( l)(1)(A), if the results of the initial biological monitoring tests show the level of CdU to be in excess of 15 μg/g Cr, or the level of CdB to be in excess of 15 μg/lwb, or the level of β 2-M to be in excess of 1,500 μg/g Cr, the employer shall comply with the requirements of subsections ( l)(3)(B)1.-2.
